Wobble uridine tRNA modification: a new vulnerability of refractory melanoma.

Mol Cell Oncol · 2018 · PMC6276846 · PMID 30525092

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

6 These data are highly significant for the patients because they suggest that targeting the U 34 -enzymes in combination with MAPK-based therapies might become a new therapeutic option to prolong treatment efficacy and to prevent tumor relapse.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.